Ind Swift Ltd
NSE:INDSWFTLTD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.47
33.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Ind Swift Ltd
Long-Term Debt
Ind Swift Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Ind Swift Ltd
NSE:INDSWFTLTD
|
Long-Term Debt
₹10.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Long-Term Debt
₹11.6B
|
CAGR 3-Years
86%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Long-Term Debt
₹3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
3%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Long-Term Debt
₹3.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-17%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Long-Term Debt
₹20.3B
|
CAGR 3-Years
102%
|
CAGR 5-Years
151%
|
CAGR 10-Years
39%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Long-Term Debt
₹12.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-6%
|
|
Ind Swift Ltd
Glance View
Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm operates in both domestic and export markets. The company is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The firm is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. The company operates through various divisions, such as Herba Plus Division, Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Herba Plus Division is engaged in the manufacturing of ayurvedic and pharmaceutical products, such as general category formulations, beta lactam, steroids and hormones, cephalosporins, oncological, soft gelatin capsules, and herbal and nutraceuticals. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte.
See Also
What is Ind Swift Ltd's Long-Term Debt?
Long-Term Debt
10.1B
INR
Based on the financial report for Mar 31, 2024, Ind Swift Ltd's Long-Term Debt amounts to 10.1B INR.
What is Ind Swift Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
6%
Over the last year, the Long-Term Debt growth was 150%. The average annual Long-Term Debt growth rates for Ind Swift Ltd have been 16% over the past three years , 9% over the past five years , and 6% over the past ten years .